Review



monocytic leukemia cell line thp1  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC monocytic leukemia cell line thp1
    Monocytic Leukemia Cell Line Thp1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 20451 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/monocytic+leukemia+cell+line+thp1/THP-1/pm42107063-172-11-20
    Average 99 stars, based on 20451 article reviews
    monocytic leukemia cell line thp1 - by Bioz Stars, 2026-10
    99/100 stars

    Images

    Related Articles

    other:

    Article Title: Response of human macrophages to gamma radiation is mediated via expression of endogenous retroviruses
    Article Snippet: The acute monocytic leukemia cell line THP1 (from S. Tsuchiya; provided by the NIH AIDS Research & Reference Reagent Program) and the human kidney fibroblasts 293T/17 (ATCC, Manassas, VA) were maintained at 37°C and 5% CO 2 in RPMI-1640 culture media (THP1) or DMEM (293T/17) supplemented with 10% FBS, penicillin/streptomycin, and L-Glutamine.

    Cell Culture:

    Article Title: Newly Synthesized Melphalan Analogs Induce DNA Damage and Mitotic Catastrophe in Hematological Malignant Cancer Cells.
    Article Snippet: .. Cell Culture, Drug Concentration, and Treatment Time The acute monocytic leukemia cell line THP1 (ATCC® TIB–202TM), promyelocytic leukemia cell line HL60 (ATCC® CCL–240TM), and the multiple myeloma cell line RPMI8226 (ATCC® CCL–155TM) were obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA). ..

    Concentration Assay:

    Article Title: Newly Synthesized Melphalan Analogs Induce DNA Damage and Mitotic Catastrophe in Hematological Malignant Cancer Cells.
    Article Snippet: .. Cell Culture, Drug Concentration, and Treatment Time The acute monocytic leukemia cell line THP1 (ATCC® TIB–202TM), promyelocytic leukemia cell line HL60 (ATCC® CCL–240TM), and the multiple myeloma cell line RPMI8226 (ATCC® CCL–155TM) were obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA). ..

    Activation Assay:

    Article Title: Cholesterol in mRNA‐Lipid Nanoparticles can be Replaced with the Synthetic Mycobacterial Monomycoloyl Glycerol Analogue MMG‐1
    Article Snippet: The single cell suspensions were stained with antibodies (Biolegend, San Diego, CA) directed against B cells (CD45R/B220, cat#103244), T cells (CD3, Cat#100232), macrophages (F4/80, Cat#123110), and dendritic cells (CD11c, Cat# 117 328). .. Activation of THP-1 Cells: The human monocytic leukemia cell line THP1 was purchased from ATCC (TIB-202). .. The cells were cultured in complete RPMI-1640 medium supplemented with 10% v/v FBS, gentamicin (Gibco Thermo Fisher), and penicillin-streptomycin (Thermo Fisher Scientific).



    Similar Products

    98
    InvivoGen acute monocytic leukemia cell line thp1 dualtm
    Acute Monocytic Leukemia Cell Line Thp1 Dualtm, supplied by InvivoGen, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/monocytic+leukemia+cell+line+thp1/THP1-Dual+Cells/pm42349786-243-11-20
    Average 98 stars, based on 1 article reviews
    acute monocytic leukemia cell line thp1 dualtm - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    99
    ATCC monocytic leukemia cell line thp1
    Monocytic Leukemia Cell Line Thp1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/monocytic+leukemia+cell+line+thp1/THP-1/pm42107063-172-11-20
    Average 99 stars, based on 1 article reviews
    monocytic leukemia cell line thp1 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    ATCC human acute monocytic leukemia cell line thp1
    Human Acute Monocytic Leukemia Cell Line Thp1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/monocytic+leukemia+cell+line+thp1/THP-1/pm41888396-57-0-28
    Average 99 stars, based on 1 article reviews
    human acute monocytic leukemia cell line thp1 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    ATCC monocyte leukemia cell line thp1
    Monocyte Leukemia Cell Line Thp1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/monocytic+leukemia+cell+line+thp1/THP-1/pm41485687-58-10-25
    Average 99 stars, based on 1 article reviews
    monocyte leukemia cell line thp1 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    ATCC acute monocytic leukemia cell line thp1
    A The box plot shows the differences in the immune and stromal cell compositions between the two groups of tumor samples with different BRRF2 expression levels based on the RNA-seq data. p values were determined via an unpaired two-side t test. Center line, median (50th percentile); box bounds, 25 and 75th percentiles (interquartile range, IQR); whiskers, extend from the bounds to the smallest or largest value within 1.5 × IQR of the bound; minima and maxima, the end points of the whiskers. B Representative images of panCK (green), BRRF2 (yellow) and CD68 (orange) staining in NPC patients’ tumor tissues. Scale bars, 5 μm. C The average distance from BRRF2 + or BRRF2 - tumor cells to CD68 + cells was measured from the IHC images. Each dot represents a patient’s tumor tissue. The experiment was performed as three independent biological replicates. ** p < 0.01 according to a two-sided paired t test. D HPMs and <t>THP1</t> cells were incubated with HEK293T-induced EVs carrying mCherry-BRRF2 for 4 h, and mCherry-BRRF2 was internalized into the cells. E HPMs and THP1 cells were incubated with HEK293T-induced EVs carrying mCherry-BRRF2 for 4 h. mCherry signals were detected by flow cytometry. The median fluorescence intensity (MFI) is shown. (Means ± SEMs of n = 3 experiments. **** p < 0.0001 according to a two-sided unpaired t test). F EVs from the HEK293T-Flag-BRRF2 cell line inhibited cGAS-STING activation induced by HT-DNA in THP1 and HPM cells. THP1 cells and HPMs were incubated with EVs from the HEK293T-Flag-BRRF2 cell line for 2 h and then transfected with 2 μg of HT-DNA for 6 h. Cell lysates were collected for immunoblotting with the indicated antibodies. The experiment was performed as three independent biological replicates. Representative images was shown. Source data are provided as a file. G After an incubation with EVs and transfection with HT-DNA, total mRNAs were extracted from THP1 cells for a qPCR analysis of the expression of the IFNβ, RANTES and IL6 mRNAs. The error bars are derived from triplicate experiments. The data are plotted as the means ± SEMs. ns indicates not significant. **** p < 0.0001 according to two-way ANOVA followed by Sidak’s multiple comparisons test.
    Acute Monocytic Leukemia Cell Line Thp1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/monocytic+leukemia+cell+line+thp1/THP-1/pmc12514055-340-2-8
    Average 99 stars, based on 1 article reviews
    acute monocytic leukemia cell line thp1 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    97
    InvivoGen human monocytic leukemia thp1 bluetm nf κb cell line
    A The box plot shows the differences in the immune and stromal cell compositions between the two groups of tumor samples with different BRRF2 expression levels based on the RNA-seq data. p values were determined via an unpaired two-side t test. Center line, median (50th percentile); box bounds, 25 and 75th percentiles (interquartile range, IQR); whiskers, extend from the bounds to the smallest or largest value within 1.5 × IQR of the bound; minima and maxima, the end points of the whiskers. B Representative images of panCK (green), BRRF2 (yellow) and CD68 (orange) staining in NPC patients’ tumor tissues. Scale bars, 5 μm. C The average distance from BRRF2 + or BRRF2 - tumor cells to CD68 + cells was measured from the IHC images. Each dot represents a patient’s tumor tissue. The experiment was performed as three independent biological replicates. ** p < 0.01 according to a two-sided paired t test. D HPMs and <t>THP1</t> cells were incubated with HEK293T-induced EVs carrying mCherry-BRRF2 for 4 h, and mCherry-BRRF2 was internalized into the cells. E HPMs and THP1 cells were incubated with HEK293T-induced EVs carrying mCherry-BRRF2 for 4 h. mCherry signals were detected by flow cytometry. The median fluorescence intensity (MFI) is shown. (Means ± SEMs of n = 3 experiments. **** p < 0.0001 according to a two-sided unpaired t test). F EVs from the HEK293T-Flag-BRRF2 cell line inhibited cGAS-STING activation induced by HT-DNA in THP1 and HPM cells. THP1 cells and HPMs were incubated with EVs from the HEK293T-Flag-BRRF2 cell line for 2 h and then transfected with 2 μg of HT-DNA for 6 h. Cell lysates were collected for immunoblotting with the indicated antibodies. The experiment was performed as three independent biological replicates. Representative images was shown. Source data are provided as a file. G After an incubation with EVs and transfection with HT-DNA, total mRNAs were extracted from THP1 cells for a qPCR analysis of the expression of the IFNβ, RANTES and IL6 mRNAs. The error bars are derived from triplicate experiments. The data are plotted as the means ± SEMs. ns indicates not significant. **** p < 0.0001 according to two-way ANOVA followed by Sidak’s multiple comparisons test.
    Human Monocytic Leukemia Thp1 Bluetm Nf κb Cell Line, supplied by InvivoGen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/monocytic+leukemia+cell+line+thp1/THP1-Blue+NF-%CE%BAB+Cells/10__1016_slash_j__molliq__2025__128553-80-6-13
    Average 97 stars, based on 1 article reviews
    human monocytic leukemia thp1 bluetm nf κb cell line - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    99
    ATCC human monocytic leukemia cell line thp1
    Prediction and validation of the potential anticancer drugs. (A) Correlation between CD163 expression and risk score in the TCGA database (p <0.0001). (B) Differences in mRNA expression of various prognostic genes and CD163 in the indirect co-culture model (*p <0.05; * *p <0.01; * * *p <0.001; * * * *p <0.0001). (C) Expression of CD163 and risk score in the indirect co-culture model. (D) Potential anticancer drugs were predicted using signature genes and a risk score. (E) The U87MG (RP) was cocultured with the PMA-induced adherent <t>THP1</t> (GP), and the treatment groups were then treated with Vorinostat. (F) Analysis of growth of U87MG and U87MG cocultured with PMA-induced adherent THP1 before and after Vorinostat treatment. (G) Expression of macrophage-related immune checkpoints of THP1 before and after the treatment with Vorinostat in the U87MG-THP1 indirect co-culture model (*p <0.05; * *p <0.01; * * *p <0.001; * * * *p <0.0001). (H) The expression of Cd163 in RAW264.7 cells at the protein level, with GL261 conditioned medium and Vorinostat as variables.
    Human Monocytic Leukemia Cell Line Thp1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/monocytic+leukemia+cell+line+thp1/THP-1/pmc12179195-79-7-21
    Average 99 stars, based on 1 article reviews
    human monocytic leukemia cell line thp1 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    98
    InvivoGen human acute monocytic leukemia cell line thp1
    Prediction and validation of the potential anticancer drugs. (A) Correlation between CD163 expression and risk score in the TCGA database (p <0.0001). (B) Differences in mRNA expression of various prognostic genes and CD163 in the indirect co-culture model (*p <0.05; * *p <0.01; * * *p <0.001; * * * *p <0.0001). (C) Expression of CD163 and risk score in the indirect co-culture model. (D) Potential anticancer drugs were predicted using signature genes and a risk score. (E) The U87MG (RP) was cocultured with the PMA-induced adherent <t>THP1</t> (GP), and the treatment groups were then treated with Vorinostat. (F) Analysis of growth of U87MG and U87MG cocultured with PMA-induced adherent THP1 before and after Vorinostat treatment. (G) Expression of macrophage-related immune checkpoints of THP1 before and after the treatment with Vorinostat in the U87MG-THP1 indirect co-culture model (*p <0.05; * *p <0.01; * * *p <0.001; * * * *p <0.0001). (H) The expression of Cd163 in RAW264.7 cells at the protein level, with GL261 conditioned medium and Vorinostat as variables.
    Human Acute Monocytic Leukemia Cell Line Thp1, supplied by InvivoGen, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/monocytic+leukemia+cell+line+thp1/THP1-Dual+Cells/pmc12152843-138-9-19
    Average 98 stars, based on 1 article reviews
    human acute monocytic leukemia cell line thp1 - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    Image Search Results


    A The box plot shows the differences in the immune and stromal cell compositions between the two groups of tumor samples with different BRRF2 expression levels based on the RNA-seq data. p values were determined via an unpaired two-side t test. Center line, median (50th percentile); box bounds, 25 and 75th percentiles (interquartile range, IQR); whiskers, extend from the bounds to the smallest or largest value within 1.5 × IQR of the bound; minima and maxima, the end points of the whiskers. B Representative images of panCK (green), BRRF2 (yellow) and CD68 (orange) staining in NPC patients’ tumor tissues. Scale bars, 5 μm. C The average distance from BRRF2 + or BRRF2 - tumor cells to CD68 + cells was measured from the IHC images. Each dot represents a patient’s tumor tissue. The experiment was performed as three independent biological replicates. ** p < 0.01 according to a two-sided paired t test. D HPMs and THP1 cells were incubated with HEK293T-induced EVs carrying mCherry-BRRF2 for 4 h, and mCherry-BRRF2 was internalized into the cells. E HPMs and THP1 cells were incubated with HEK293T-induced EVs carrying mCherry-BRRF2 for 4 h. mCherry signals were detected by flow cytometry. The median fluorescence intensity (MFI) is shown. (Means ± SEMs of n = 3 experiments. **** p < 0.0001 according to a two-sided unpaired t test). F EVs from the HEK293T-Flag-BRRF2 cell line inhibited cGAS-STING activation induced by HT-DNA in THP1 and HPM cells. THP1 cells and HPMs were incubated with EVs from the HEK293T-Flag-BRRF2 cell line for 2 h and then transfected with 2 μg of HT-DNA for 6 h. Cell lysates were collected for immunoblotting with the indicated antibodies. The experiment was performed as three independent biological replicates. Representative images was shown. Source data are provided as a file. G After an incubation with EVs and transfection with HT-DNA, total mRNAs were extracted from THP1 cells for a qPCR analysis of the expression of the IFNβ, RANTES and IL6 mRNAs. The error bars are derived from triplicate experiments. The data are plotted as the means ± SEMs. ns indicates not significant. **** p < 0.0001 according to two-way ANOVA followed by Sidak’s multiple comparisons test.

    Journal: Nature Communications

    Article Title: Extracellular vesicles derived EBV tegument protein BRRF2 suppresses cGAS phase separation to promote anti-viral innate immune evasion

    doi: 10.1038/s41467-025-64037-2

    Figure Lengend Snippet: A The box plot shows the differences in the immune and stromal cell compositions between the two groups of tumor samples with different BRRF2 expression levels based on the RNA-seq data. p values were determined via an unpaired two-side t test. Center line, median (50th percentile); box bounds, 25 and 75th percentiles (interquartile range, IQR); whiskers, extend from the bounds to the smallest or largest value within 1.5 × IQR of the bound; minima and maxima, the end points of the whiskers. B Representative images of panCK (green), BRRF2 (yellow) and CD68 (orange) staining in NPC patients’ tumor tissues. Scale bars, 5 μm. C The average distance from BRRF2 + or BRRF2 - tumor cells to CD68 + cells was measured from the IHC images. Each dot represents a patient’s tumor tissue. The experiment was performed as three independent biological replicates. ** p < 0.01 according to a two-sided paired t test. D HPMs and THP1 cells were incubated with HEK293T-induced EVs carrying mCherry-BRRF2 for 4 h, and mCherry-BRRF2 was internalized into the cells. E HPMs and THP1 cells were incubated with HEK293T-induced EVs carrying mCherry-BRRF2 for 4 h. mCherry signals were detected by flow cytometry. The median fluorescence intensity (MFI) is shown. (Means ± SEMs of n = 3 experiments. **** p < 0.0001 according to a two-sided unpaired t test). F EVs from the HEK293T-Flag-BRRF2 cell line inhibited cGAS-STING activation induced by HT-DNA in THP1 and HPM cells. THP1 cells and HPMs were incubated with EVs from the HEK293T-Flag-BRRF2 cell line for 2 h and then transfected with 2 μg of HT-DNA for 6 h. Cell lysates were collected for immunoblotting with the indicated antibodies. The experiment was performed as three independent biological replicates. Representative images was shown. Source data are provided as a file. G After an incubation with EVs and transfection with HT-DNA, total mRNAs were extracted from THP1 cells for a qPCR analysis of the expression of the IFNβ, RANTES and IL6 mRNAs. The error bars are derived from triplicate experiments. The data are plotted as the means ± SEMs. ns indicates not significant. **** p < 0.0001 according to two-way ANOVA followed by Sidak’s multiple comparisons test.

    Article Snippet: The human acute monocytic leukemia cell line THP1 (ATCC, #TIB202), the murine breast cancer cell line EMT6 (ATCC, #CRL-2755), and the human NPC cell lines HONE1, CNE2, HK1 (provided from Dr. Sai-Wah Tsao, University of Hong Kong), and Raji (ATCC, #CCL-86), and latent EBV-infected CNE2 (EBV + CNE2) cells were cultured with RPMI-1640 containing 10% fetal bovine serum at 37 °C with 5% CO 2 .

    Techniques: Expressing, RNA Sequencing, Staining, Incubation, Flow Cytometry, Fluorescence, Activation Assay, Transfection, Western Blot, Derivative Assay

    Prediction and validation of the potential anticancer drugs. (A) Correlation between CD163 expression and risk score in the TCGA database (p <0.0001). (B) Differences in mRNA expression of various prognostic genes and CD163 in the indirect co-culture model (*p <0.05; * *p <0.01; * * *p <0.001; * * * *p <0.0001). (C) Expression of CD163 and risk score in the indirect co-culture model. (D) Potential anticancer drugs were predicted using signature genes and a risk score. (E) The U87MG (RP) was cocultured with the PMA-induced adherent THP1 (GP), and the treatment groups were then treated with Vorinostat. (F) Analysis of growth of U87MG and U87MG cocultured with PMA-induced adherent THP1 before and after Vorinostat treatment. (G) Expression of macrophage-related immune checkpoints of THP1 before and after the treatment with Vorinostat in the U87MG-THP1 indirect co-culture model (*p <0.05; * *p <0.01; * * *p <0.001; * * * *p <0.0001). (H) The expression of Cd163 in RAW264.7 cells at the protein level, with GL261 conditioned medium and Vorinostat as variables.

    Journal: Frontiers in Oncology

    Article Title: Interrogation of macrophage-related prognostic signatures reveals a potential immune-mediated therapy strategy by histone deacetylase inhibition in glioma

    doi: 10.3389/fonc.2025.1554845

    Figure Lengend Snippet: Prediction and validation of the potential anticancer drugs. (A) Correlation between CD163 expression and risk score in the TCGA database (p <0.0001). (B) Differences in mRNA expression of various prognostic genes and CD163 in the indirect co-culture model (*p <0.05; * *p <0.01; * * *p <0.001; * * * *p <0.0001). (C) Expression of CD163 and risk score in the indirect co-culture model. (D) Potential anticancer drugs were predicted using signature genes and a risk score. (E) The U87MG (RP) was cocultured with the PMA-induced adherent THP1 (GP), and the treatment groups were then treated with Vorinostat. (F) Analysis of growth of U87MG and U87MG cocultured with PMA-induced adherent THP1 before and after Vorinostat treatment. (G) Expression of macrophage-related immune checkpoints of THP1 before and after the treatment with Vorinostat in the U87MG-THP1 indirect co-culture model (*p <0.05; * *p <0.01; * * *p <0.001; * * * *p <0.0001). (H) The expression of Cd163 in RAW264.7 cells at the protein level, with GL261 conditioned medium and Vorinostat as variables.

    Article Snippet: Human glioma cell lines A172 and U87MG, human monocytic leukemia cell line THP1, mouse macrophages cell line RAW264.7 were obtained from American Type Culture Collection (ATCC) (Manassas, VA, USA).

    Techniques: Biomarker Discovery, Expressing, Co-Culture Assay